Table 3 Meta-analysis results for circRNAs expression with clinicopathological features
| Â | Tumor promoter | Tumor suppressor | ||
|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Gender (M/W) | 1.25 (0.99–1.58) | 0.061 | 1.9 (1.02–3.51) | 0.042 |
Age | 1.32 (1.03–1.68) | 0.026 | 0.46 (0.15–1.39) | 0.014 |
Tumor size | 3.48 (2.61–4.63) | 0.000 | 0.49 (0.26–0.9) | 0.022 |
Tumor grade (III + IV/I + II) | 4.24 (3.26–5.52) | 0.000 | 0.12(0.05–0.27) | 0.000 |
Tumor location (Supra/Infra) | 1.22 (0.87–1.70) | 0.248 | 1.99 (0.7–5.62) | 0.195 |
KPS | 0.21(0.06–0.71) | 0.012 | 0.98(0.19–4.99) | 0.981 |
Family history of cancer (Y/N) | 1.43 (0.92–2.21) | 0.108 | 0.45 (0.1–1.98) | 0.289 |